migraines

Impax commenced shipment of authorized generic Zomig

Impax commenced shipment of authorized generic Zomig

Yahoo/Fly on the Wall

FDA declines to approve new Allergan migraine drug

FDA declines to approve new Allergan migraine drug

Reuters

3 Biotechs With Upcoming Product Launches

3 Biotechs With Upcoming Product Launches

Seeking Alpha

Why Zohydro May Or May Not Be Approved

Why Zohydro May Or May Not Be Approved

Seeking Alpha

Reanalysis of Clinical Trial Data Confirms LipiGesic M has Robust Efficacy for Treatment of Migraine Headache and Associated Symptoms

Reanalysis of Clinical Trial Data Confirms LipiGesic M has Robust Efficacy for Treatment of Migraine Headache and Associated Symptoms

Yahoo/PR Newswire

Redhill Seeks Migraine, Oncology Partners After Nasdaq Listing

Redhill Seeks Migraine, Oncology Partners After Nasdaq Listing

Bloomberg

This Biotech's on the NuPathe to Success

This Biotech's on the NuPathe to Success

Motley Fool

NuPathe Wins U.S. FDA Approval for Migraine Skin Patch

NuPathe Wins U.S. FDA Approval for Migraine Skin Patch

Bloomberg

FDA Decision On MAP's Levadex Approaching, Stock Starting To Reflect Optimism

FDA Decision On MAP's Levadex Approaching, Stock Starting To Reflect Optimism

Seeking Alpha

Bristol-Myers May Sell Experimental Migraine Drug

Bristol-Myers May Sell Experimental Migraine Drug

Bloomberg